DAVID OHOTNICKY: Open Payments
NPI 1699067314 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,387 in 188 payments from 30 companies in 2025. Trend: 2023 $5,335 · 2024 $4,898 · 2025 $4,387
Food & beverage: $4,344Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $508 |
| Lilly USA, LLC | 17 | $439 |
| Amgen Inc. | 19 | $398 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $332 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $260 |
| Tandem Diabetes Care, Inc. | 4 | $225 |
| Dexcom, Inc. | 12 | $217 |
| Xeris Pharmaceuticals, Inc. | 10 | $216 |
| Ascendis Pharma Endocrinology Inc | 9 | $198 |
| Mannkind Corporation | 7 | $181 |
Products named: JARDIANCE, Ozempic, Kerendia, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, EVENITY, Yorvipath, AFREZZA.
Industry payments across CT — which companies pay providers there.
